TRT and peptide protocols run simultaneously in a large portion of Protocol users. Each compound needs separate logging. Here's how they interact and what a combined protocol tracker handles.
TRT addresses testosterone deficiency and its effects: low energy, poor body composition, reduced libido, cognitive fog. Research peptides address different targets: BPC-157 and TB-500 for recovery and injury repair, CJC-1295/Ipamorelin for growth hormone secretion and sleep quality, PT-141 for libido, BPC-157 for gut health. These goals don't conflict — they address different physiological systems. The protocols are often run simultaneously, with TRT as the foundational layer and peptides cycled on top.
The practical tracking challenge: each compound has different dosing frequencies, different injection sites (testosterone is typically intramuscular; peptides are typically subcutaneous), different storage requirements (reconstituted peptides refrigerated; testosterone at room temperature), and different bloodwork implications. A single tracking app that handles both eliminates the spreadsheet or dual-app system most users otherwise resort to.
| Compound | Log per injection | Periodic tracking |
|---|---|---|
| Testosterone (TRT) | Dose, ester, injection site (IM zones), date/time | Bloodwork panel every 90 days |
| BPC-157 | Dose in mcg, reconstitution data, SubQ site | Cycle length, injury response notes |
| CJC-1295/Ipamorelin | Dose per peptide, injection timing (pre-sleep), site | Sleep quality, GH-related symptom log |
| HCG (adjunct) | Dose in IU, injection site, date | Estradiol (HCG can raise E2) |
Protocol tracks all compounds on the same timeline. The PK plotter shows active blood concentration curves for multiple compounds simultaneously — useful for timing peptide doses around testosterone peaks and troughs.
TRT tracker guide → · Bloodwork guide → · Protocol compound library →